Matches in Wikidata for { <http://www.wikidata.org/entity/Q38669314> ?p ?o ?g. }
- Q38669314 description "2017 nî lūn-bûn" @default.
- Q38669314 description "2017年の論文" @default.
- Q38669314 description "2017年論文" @default.
- Q38669314 description "2017年論文" @default.
- Q38669314 description "2017年論文" @default.
- Q38669314 description "2017年論文" @default.
- Q38669314 description "2017年論文" @default.
- Q38669314 description "2017年论文" @default.
- Q38669314 description "2017年论文" @default.
- Q38669314 description "2017年论文" @default.
- Q38669314 description "2017年论文" @default.
- Q38669314 description "2017年论文" @default.
- Q38669314 description "2017年论文" @default.
- Q38669314 description "2017년 논문" @default.
- Q38669314 description "article científic" @default.
- Q38669314 description "article scientific" @default.
- Q38669314 description "article scientifique" @default.
- Q38669314 description "articol științific" @default.
- Q38669314 description "articolo scientifico" @default.
- Q38669314 description "artigo científico" @default.
- Q38669314 description "artigo científico" @default.
- Q38669314 description "artigo científico" @default.
- Q38669314 description "artikel ilmiah" @default.
- Q38669314 description "artikull shkencor" @default.
- Q38669314 description "artikulong pang-agham" @default.
- Q38669314 description "artykuł naukowy" @default.
- Q38669314 description "artículo científico" @default.
- Q38669314 description "artículu científicu espublizáu en 2017" @default.
- Q38669314 description "bilimsel makale" @default.
- Q38669314 description "bài báo khoa học" @default.
- Q38669314 description "naučni članak" @default.
- Q38669314 description "scienca artikolo" @default.
- Q38669314 description "scientific article published on 23 June 2017" @default.
- Q38669314 description "scientific article published on 23 June 2017" @default.
- Q38669314 description "scientific article published on 23 June 2017" @default.
- Q38669314 description "teaduslik artikkel" @default.
- Q38669314 description "tieteellinen artikkeli" @default.
- Q38669314 description "tudományos cikk" @default.
- Q38669314 description "vedecký článok" @default.
- Q38669314 description "vetenskaplig artikel" @default.
- Q38669314 description "videnskabelig artikel" @default.
- Q38669314 description "vitenskapelig artikkel" @default.
- Q38669314 description "vitskapeleg artikkel" @default.
- Q38669314 description "vědecký článek" @default.
- Q38669314 description "wetenschappelijk artikel" @default.
- Q38669314 description "wissenschaftlicher Artikel" @default.
- Q38669314 description "επιστημονικό άρθρο" @default.
- Q38669314 description "мақолаи илмӣ" @default.
- Q38669314 description "наукова стаття, опублікована в червні 2017" @default.
- Q38669314 description "научна статия" @default.
- Q38669314 description "научная статья" @default.
- Q38669314 description "научни чланак" @default.
- Q38669314 description "научни чланак" @default.
- Q38669314 description "מאמר מדעי" @default.
- Q38669314 description "مقالة علمية نشرت في 23 يونيو 2017" @default.
- Q38669314 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38669314 description "บทความทางวิทยาศาสตร์" @default.
- Q38669314 description "სამეცნიერო სტატია" @default.
- Q38669314 name "Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy" @default.
- Q38669314 name "Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy" @default.
- Q38669314 name "Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy" @default.
- Q38669314 type Item @default.
- Q38669314 label "Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy" @default.
- Q38669314 label "Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy" @default.
- Q38669314 label "Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy" @default.
- Q38669314 prefLabel "Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy" @default.
- Q38669314 prefLabel "Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy" @default.
- Q38669314 prefLabel "Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy" @default.
- Q38669314 P1433 Q38669314-A4E7CB02-595B-449E-B159-472FA5613E85 @default.
- Q38669314 P1476 Q38669314-029CFA03-0FDE-41D5-A79A-016C4474CCAF @default.
- Q38669314 P2093 Q38669314-174C855D-E0C9-4145-ADE3-AAAC68D7FF94 @default.
- Q38669314 P2093 Q38669314-34569E02-E093-4D43-BD28-D28C30F14E10 @default.
- Q38669314 P2093 Q38669314-3F459F86-6E0D-4C97-8188-39A7168A2D86 @default.
- Q38669314 P2093 Q38669314-4AE572DF-A8FC-45B3-B4F0-2400BF6C5996 @default.
- Q38669314 P2093 Q38669314-76EEA620-EE19-43EF-A5B6-252BFE9EF0FD @default.
- Q38669314 P2093 Q38669314-7744ECB3-3E3B-4898-B37F-48E75AB57178 @default.
- Q38669314 P2093 Q38669314-A01DCA19-0C72-411A-B263-12B77EA121EF @default.
- Q38669314 P2093 Q38669314-A79A3A62-BD65-4768-94A0-8C1382FDC691 @default.
- Q38669314 P2093 Q38669314-C6508775-B9B8-494A-A238-E755D217F969 @default.
- Q38669314 P2093 Q38669314-C8268A3C-CA5F-47E1-BB56-D23BC537B1EE @default.
- Q38669314 P2093 Q38669314-C9DB093E-7074-49B1-A011-B42D1385522C @default.
- Q38669314 P2093 Q38669314-D19878CA-496E-4744-8006-06A9E01F9418 @default.
- Q38669314 P2093 Q38669314-E1DE8026-EEE7-443E-909C-6242404D31DD @default.
- Q38669314 P2093 Q38669314-F2C27ECB-AD4D-4829-B35C-F30D3EF64CFB @default.
- Q38669314 P31 Q38669314-C9106715-765B-45FB-9814-2D3ED450E109 @default.
- Q38669314 P356 Q38669314-BF2FDBA5-2728-4EA5-A396-9705FB533AC9 @default.
- Q38669314 P407 Q38669314-30725965-5F01-4449-B051-989868A584D5 @default.
- Q38669314 P50 Q38669314-9D49EAA5-F22C-43BB-AC24-4C02E811A916 @default.
- Q38669314 P50 Q38669314-B1E9B9EE-0F47-4620-8C06-0C43A6CECA8E @default.
- Q38669314 P577 Q38669314-6140149E-EEEE-459C-BE11-839981CE6A59 @default.
- Q38669314 P698 Q38669314-F59BCF9E-EF06-45DC-B61B-B60B7B171EF1 @default.
- Q38669314 P921 Q38669314-8483D3A1-1FA4-4ABC-BCD7-936456BA3039 @default.
- Q38669314 P921 Q38669314-E7E86796-A6AF-4AAE-8C91-C5718FB6ADB2 @default.
- Q38669314 P356 J.CLLC.2017.06.002 @default.
- Q38669314 P698 28729180 @default.
- Q38669314 P1433 Q332299 @default.
- Q38669314 P1476 "Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy" @default.
- Q38669314 P2093 "Andrea Fülöp" @default.
- Q38669314 P2093 "Bushi Wang" @default.
- Q38669314 P2093 "Charles Dayen" @default.